"covishield"

The Centre can use its powers under Section 92, 100 & 102 of the Patents Act to increase production of Covid vaccines

States like Telangana opting for global tenders to procure vaccine is a pragmatic decision, given the Centre's opaque policy

The state government has placed an order for over one crore doses of vaccine to accelerate the vaccination drive in the state.

Across the globe medical professionals advise one should get the vaccine as soon as possible.

Majority of private hospitals, who were facing difficulties in sourcing vaccines, expected to launch drive in the next few days

India rolled out the third phase of its COVID-19 vaccination drive for those in the age group of 18-45 years on Saturday.

Amaravati: The Andhra Pradesh government on Saturday placed an order for purchase of 4.08 crore doses each of Covaxin and Covishield for vaccinating 2.04 crore people in the 18-45 age group from May 1. Government Principal Secretary (Covid Management and Vaccination) Muddada Ravichandra wrote letters to Bharat Biotech MD Krishna Yella and Serum Institute of […]

Mocking the BJP over its slogan of 'One nation, one party, one leader', she stressed that every Indian needs vaccine free of cost, regardless of their age and location.

The Centre on Monday announced a liberalised vaccine policy, making all adults above 18 years of age eligible for getting vaccination from May 1.

SII said it will address the limited capacity by scaling up the vaccine production over the next two months.

Govt must now work out a mutually agreeable pricing and procurement strategy for a smooth rollout of the foreign vaccines

Now, Kerala Police too has latched on to the dance video in an endeavour to spread awareness among the people on the need to get vaccinated against the novel coronavirus.

So far, Telangana State has received 26.78 lakh doses out of which 22.50 lakh doses have been consumed.

In a statement on Friday, the WHO said that based on available data the review team found no increased risk of blood clotting conditions in people who received the AstraZeneca-Oxford vaccine.

India recorded 28,903 new infections--the highest so far this year-- taking the total COVID-19 tally to 1,14,38,734, according to the Union Health ministry

With an enthusiastic push from the civic bodies, we are slowly but steadily approaching our target goals

The former Union minister was administered 'Covishield' vaccine, which is manufactured by Pune-based Serum Institute of India (SII).

Involving private sector will accelerate the process and ensure there is minimum wastage of the vaccines

Oxford-AstraZeneca's Covishield is being manufactured by Pune-based Serum Institute.

Covishield is the brand name for the AstraZeneca-Oxford University COVID-19 vaccine.